Financials

  • Market Capitalization 1.3 B
  • Employee 1 800
  • Founded 1984
  • CEO James Patrick Mackin
  • Website www.artivion.com
  • Headquarter Delaware, United States
  • FIGI BBG000BMLVJ6
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
217.19
Price to sales ratio
4.87

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2208
ATEC
Alphatec Holdings, Inc. - Common Stock
9.43 USD-1.46%-0.53%+1.51%-41.32%1.46 B USD
2273
IART
Integra LifeSciences Holdings Corporation - Common Stock
16.90 USD+0.30%+0.96%-8.65%+4.84%1.31 B USD
2354
PRCT
PROCEPT BioRobotics Corporation - Common Stock
20.85 USD+1.21%-3.83%+16.48%-41.55%1.19 B USD
2363
BVS
Bioventus Inc. - Class A Common Stock
13.85 USD+0.44%-3.69%+6.29%+89.99%1.16 B USD

Frequently asked questions about Artivion, Inc.

What is the Artivion, Inc. stock price today?

The current price of Artivion, Inc. (AORT) is 26.74. Over the past 24 hours, the stock has changed by +0.22%. Follow the AORT chart for real-time price dynamics.

What is the stock ticker of Artivion, Inc.?

Artivion, Inc. trades under the ticker AORT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Artivion, Inc. stock going up?

AORT has changed by -4.81% over the last week, -2.73% over the last month, and -38.43% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Artivion, Inc.?

Artivion, Inc. currently has a market capitalization of 1.3 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Artivion, Inc. release financial reports?

Yes. You can track Artivion, Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Artivion, Inc. earnings last quarter?

Last quarter, Artivion, Inc. reported earnings of -0.28 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Artivion, Inc. revenue for the last quarter?

Artivion, Inc. reported quarterly revenue of 125.76 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Artivion, Inc. net income for the last quarter?

Artivion, Inc. reported net income of -13.51 M for the last quarter. The previous quarter showed 1.42 M, which means net income changed by -1053.42%.

How many employees does Artivion, Inc. have?

As of the latest available data, Artivion, Inc. has 1 800 employees. Workforce size can provide additional context about the company's scale and operations.

What is Artivion, Inc. EBITDA?

Artivion, Inc. EBITDA is -1.62 M, and its EBITDA margin is -1.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Artivion, Inc. stock?

You can buy Artivion, Inc. (AORT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Artivion, Inc. stock?

Investing in Artivion, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AORT chart and related analysis on metatrader.com as part of your research.

Artivion, Inc. Common Stock

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

News